Literature DB >> 26826597

Characterization of clinical and immunological features in patients coinfected with dengue virus and HIV.

Amanda Torrentes-Carvalho1, Eugênio Damaceno Hottz2, Cintia Ferreira Marinho3, Jéssica Badolato-Corrêa da Silva3, Luzia Maria de Oliveira Pinto3, Luciana Gomes Fialho3, Fernando Augusto Bozza2, Rivaldo Venâncio Cunha4, Paulo Vieira Damasco5, Claire Fernandes Kubelka3, Elzinandes Leal de Azeredo6.   

Abstract

The pathogenesis of dengue in subjects coinfected with HIV remains largely unknown. We investigate clinical and immunological parameters in coinfected DENV/HIV patients. According to the new dengue classification, most coinfected DENV/HIV patients presented mild clinical manifestations of dengue infection. Herein, we show that DENV/HIV coinfected patients had higher CD8 T cells percentages reflected as a lower CD4/CD8 ratio. Furthermore, CCR5 expression on CD4 T cells and CD107a expression on both T subsets were significantly higher in coinfected patients when compared with monoinfected DENV and HIV individuals respectively. Increased inflammatory response was observed in treated HAART coinfected patients despite undetectable HIV load. These data indicate that DENV infection may influence the clinical profile and immune response in individuals concomitantly infected with HIV.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Coinfection; Cytokines; Dengue; HIV; Lymphocytes

Mesh:

Substances:

Year:  2016        PMID: 26826597     DOI: 10.1016/j.clim.2016.01.005

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  5 in total

1.  Dengue Infection in a Human Immunodeficiency Virus-1 Positive Patient Chronically Infected with Hepatitis B Virus in Western Mexico.

Authors:  Iván Delgado-Enciso; Francisco Espinoza-Gómez; Rodolfo Ochoa-Jiménez; Salvador Valle-Reyes; Clemente Vásquez; Uriel A López-Lemus
Journal:  Am J Trop Med Hyg       Date:  2016-11-28       Impact factor: 2.345

Review 2.  Current concerns and perspectives on Zika virus co-infection with arboviruses and HIV.

Authors:  Hussin A Rothan; Mehdi R M Bidokhti; Siddappa N Byrareddy
Journal:  J Autoimmun       Date:  2018-01-17       Impact factor: 7.094

3.  Dengue Virus Coinfection in Human Immunodeficiency Virus-1-Infected Patients on the West Coast of Mexico.

Authors:  Francisco Espinoza-Gómez; Iván Delgado-Enciso; Salvador Valle-Reyes; Rodolfo Ochoa-Jiménez; Conrado Arechiga-Ramírez; José L Gámez-Arroyo; Roberto Vázquez-Campuzano; Carmen Guzmán-Bracho; Clemente Vásquez; Uriel A López-Lemus
Journal:  Am J Trop Med Hyg       Date:  2017-07-19       Impact factor: 2.345

4.  Placental Histopathology and Clinical Presentation of Severe Congenital Zika Syndrome in a Human Immunodeficiency Virus-Exposed Uninfected Infant.

Authors:  Kíssila Rabelo; Regina Célia de Souza Campos Fernandes; Luiz José de Souza; Thais Louvain de Souza; Flávia Barreto Dos Santos; Priscila Conrado Guerra Nunes; Elzinandes Leal de Azeredo; Natália Gedeão Salomão; Gisela Freitas Trindade; Carlos A Basílio-de-Oliveira; Jorge José de Carvalho; Enrique Medina-Acosta; Marciano Viana Paes
Journal:  Front Immunol       Date:  2017-12-07       Impact factor: 7.561

5.  Apoptosis characterization in mononuclear blood leukocytes of HIV patients during dengue acute disease.

Authors:  Amanda Torrentes-Carvalho; Juan Camilo Sánchez-Arcila; Tamiris Azamor; Luciana Santos Barbosa; Eugênio Damaceno Hottz; Mariana Gandini; Fernando Augusto Bozza; Rivaldo Venâncio da Cunha; Luzia Maria de Oliveira Pinto; Paulo Vieira Damasco; Elzinandes Leal de Azeredo
Journal:  Sci Rep       Date:  2020-04-14       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.